Skip to main content

REVIEW article

Front. Genome Ed.
Sec. Genome Editing in Animals
Volume 6 - 2024 | doi: 10.3389/fgeed.2024.1467080
This article is part of the Research Topic Insights in Genome Editing in Animals 2023/2024 View all 6 articles

Global Regulatory Policies for Animal Biotechnology: Overview, Opportunities and Challenges

Provisionally accepted
  • 1 United States Department of Agriculture (USDA), Washington, United States
  • 2 Virginia Tech, Blacksburg, Virginia, United States
  • 3 Commonwealth Scientific and Industrial Research Organisation, Geelong, Australia

The final, formatted version of the article will be published soon.

    Genome editing (GnEd) has the potential to provide many benefits to animal agriculture, offering a means for achieving rapid growth, disease resistance, and novel phenotypes. The technology has the potential to be useful for rapidly incorporating traits into existing selectively bred animals without the need for crossbreeding and backcrossing. Yet only four products from animals created via biotechnology, all growth-enhanced fishes, have reached commercialization and only on a limited scale. The past failure of genetically engineered (or GM) products to reach conventional producers can largely be attributed to the high cost of meeting GMO regulatory requirements. We review the history of GMO regulations internationally, noting the influence of Codex Alimentarius on the development of many existing regulatory frameworks. We highlight new regulatory approaches for GnEd organisms, first developed by Argentina, and the adoption of similar approaches by other countries. Such new regulatory approaches allow GnEd organisms that could have been developed by conventional means to be regulated under the same rules as conventional organisms and in the future is likely to enhance the opportunity for biotech animals to enter production. Treating certain GnEd products as conventional has had a large impact on the variety of biotechnological innovations successfully navigating regulatory processes. We suggest that for the full potential of GnEd technologies to be realized, enabling public policies are needed to facilitate use of GnEd as a breeding tool to incorporate new traits within existing animal breeding programs, rather than only a tool to create distinct new products. Table 2. Global approaches to regulation of agricultural applications of precision biotechnology (genome editing). 1038 Category Defining Questions Categories of Products of Precision Breeding Techniques Null Segregant Could be obtained via "conventional crossbreeding" or via mutagenesis? yes yes yes no yes Nucleic acid template? no short long yes NA "Foreign" DNA (Synthetic or Transgenic) no no no yes NA * FAS GAIN: https://gain.fas.usda.gov/#/ (updated annually) Details on country policies available in the USDA GAIN system and in the weblinks below Weblinks to Country Policies:

    Keywords: gene transfer, Genome editing, Biotechnology policy, regulatory oversight, Commercialization

    Received: 19 Jul 2024; Accepted: 30 Aug 2024.

    Copyright: © 2024 Wray-Cahen, Hallerman and Tizard. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Diane Wray-Cahen, United States Department of Agriculture (USDA), Washington, United States

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.